TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.6500
+0.0057 (0.88%)
Aug 17, 2026, 4:00 PM EDT - Market closed
TELA Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -41.18 | -38.83 | -37.84 | -46.66 | -44.3 | -33.28 |
Depreciation & Amortization | 1 | 1.01 | 1.01 | 0.81 | 1.19 | 0.54 |
Loss (Gain) From Sale of Assets | 0.02 | - | -7.58 | -0.01 | - | 0 |
Stock-Based Compensation | 3.2 | 3.8 | 4.36 | 5.03 | 3.99 | 3.66 |
Other Operating Activities | 4.89 | 4.31 | 3.32 | 1.96 | 3.72 | 2.1 |
Change in Accounts Receivable | 1.51 | -0.11 | -0.76 | -3.06 | -2.42 | -1.55 |
Change in Inventory | -2.41 | -0.5 | -2.97 | -2.72 | -6.07 | -5.19 |
Change in Accounts Payable | 1.17 | 0.14 | 0.48 | 0.01 | -0.88 | 1.6 |
Change in Other Net Operating Assets | 0.66 | 1.97 | -1.62 | 3.78 | 4.04 | 1.69 |
Operating Cash Flow | -31.14 | -28.22 | -41.6 | -40.86 | -40.75 | -30.43 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -0.48 | -0.45 | -0.99 | -0.61 | -0.87 | -0.63 |
Sale of Property, Plant & Equipment | 1.41 | 1.29 | 5.44 | 0.01 | - | - |
Sale (Purchase) of Intangibles | - | - | - | - | -1 | - |
Investing Cash Flow | 0.93 | 0.85 | 4.45 | -0.6 | -1.87 | -0.63 |
Long-Term Debt Issued | - | 60 | - | - | 40 | - |
Total Debt Issued | 60 | 60 | - | - | 40 | - |
Long-Term Debt Repaid | - | -42.42 | - | - | -30 | - |
Total Debt Repaid | -42.42 | -42.42 | - | - | -30 | - |
Net Debt Issued (Repaid) | 17.58 | 17.58 | - | - | 10 | - |
Issuance of Common Stock | 11.9 | 11.93 | 43.43 | 46.56 | 34.47 | 0.59 |
Repurchase of Common Stock | -0.12 | -0.21 | -0.37 | -0.29 | -0.16 | - |
Other Financing Activities | -3.8 | -3.55 | - | - | -3.46 | - |
Financing Cash Flow | 25.56 | 25.75 | 43.06 | 46.27 | 40.85 | 0.59 |
Foreign Exchange Rate Adjustments | 0.03 | -0.22 | 0.03 | 0.16 | -0.14 | 0.01 |
Net Cash Flow | -4.62 | -1.84 | 5.94 | 4.98 | -1.91 | -30.46 |
Free Cash Flow | -31.62 | -28.67 | -42.58 | -41.47 | -41.62 | -31.06 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -39.57% | -35.71% | -61.45% | -70.94% | -100.49% | -105.42% |
Free Cash Flow Per Share | -0.60 | -0.61 | -1.49 | -1.81 | -2.56 | -2.15 |
Levered Free Cash Flow | -17.71 | -16.95 | -26.73 | -25.81 | -27.42 | -19.41 |
Unlevered Free Cash Flow | -13.36 | -13.68 | -23.43 | -22.55 | -24.89 | -17.16 |
Cash Interest Paid | 5.7 | 4.72 | 4.07 | 4.62 | 3.39 | 2.93 |
Change in Working Capital | 0.93 | 1.5 | -4.87 | -1.99 | -5.34 | -3.46 |